Table 2.
Chr | Position (SNPid) | Nearest gene | EA/OA | Cohort | EAF | OR (95%CI) | P |
6 | 31442744 (rs3093958) | HCP5/MICA | G/A | All | 0.245/0.094 | 4.49 (3.62–5.57) | 3.97 × 10−42 |
M | 0.117/0.094 | 1.90 (1.28–2.82) | 1.47 × 10−3 | ||||
F | 0.290/0.094 | 6.39 (5.01–8.14) | 7.46 × 10−51 | ||||
11 | 116158033 (rs73007767) | LINC02151 | G/T | All | 0.129/0.087 | 1.85 (1.48–2.30) | 4.36 × 10−8 |
M | 0.133/0.087 | 1.80 (1.26–2.56) | 1.14 × 10−3 | ||||
F | 0.128/0.087 | 1.81 (1.42–2.32) | 2.17 × 10−6 |
Positions are in build hg38; Chr, chromosome; EA/OA, effect allele/other allele; EAF, effect allele frequency in cases and controls; meta-analysis is based on early-onset myasthenia gravis cases from the US and Italian cohorts (595 cases and 2,718 controls).